Experimental Models for Pharmacokinetic and Pharmacodynamic Studies of Antifungals Used in Cryptococcosis Treatment
- 13 June 2022
- journal article
- review article
- Published by Taylor & Francis in Future Microbiology
- Vol. 17 (12) , 969-982
Abstract
Studies on cryptococcosis in the mammal animal model have demonstrated the occurrence of central nervous system infection and similarities in fungal pathogenicity with clinical and immunological fe...Keywords
All Related Versions
Funding Information
- Conselho Nacional de Desenvolvimento Científico e Tecnológico (303373/2019-9)
This publication has 75 references indexed in Scilit:
- Derivation of blood-brain barrier endothelial cells from human pluripotent stem cellsNature Biotechnology, 2012
- Characterization of a microfluidic in vitro model of the blood-brain barrier (μBBB)Lab on a Chip, 2012
- Rabbit as an animal model for experimental researchDental Research Journal, 2012
- Efficacy of intravenous amphotericin B-polybutylcyanoacrylate nanoparticles against cryptococcal meningitis in miceInternational Journal of Nanomedicine, 2011
- Correlation of the in vitro antifungal drug susceptibility with the in vivo activity of fluconazole in a murine model of cerebral infection caused by Cryptococcus gattiiEuropean Journal of Clinical Microbiology & Infectious Diseases, 2010
- Rats!Disease Models & Mechanisms, 2009
- Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDSAIDS, 2009
- Population Pharmacokinetics of Fluconazole in Young InfantsAntimicrobial Agents and Chemotherapy, 2008
- Challenge of Drosophila melanogaster with Cryptococcus neoformans and Role of the Innate Immune ResponseEukaryotic Cell, 2004
- In Vivo Postantibiotic Effect in a Thigh Infection in Neutropenic MiceThe Journal of Infectious Diseases, 1988